Home > Boards > US OTC > Medical - Equipment >

Lifeline Biotechnologies, Inc. (LLBO)

Add LLBO Price Alert      Hide Sticky   Hide Intro
Moderator: Arnie1, leprisonnier
Search This Board: 
Last Post: 9/17/2020 2:47:49 AM - Followers: 278 - Board type: Free - Posts Today: 0

Cyrcadia Asia, Hong Konghttps://www.rouse.com/magazine/news/rouse-ventures-team-scores-win-for-breast-cancer-detection-wearable-cyrcadia/



Lifeline Biotechnologies Provides Information To The Public And Its Shareholders

Cyrcadia, Inc. – 2017 Year End and 2018 Look Forward Newsletter

by admin | Feb 21, 2018 | NewsFebruary 27, 2018 Cyrcadia, Inc. (“CI”) extends its thanks and appreciation in your interest and support of our endeavors. We are taking this opportunity to provide an update, as well as apprise you of upcoming expectations. License and Cooperation Agreement with Cyrcadia Asia (“CA”) – Status Earlier in 2017 CI entered into an Agreement with CA, whereby CA assumed the responsibility and funding of the design, development and delivery of a scalable, commercializable iTBra™ system including upgraded hardware and the full suite of application software as well as automation of our proprietary Artificial Intelligence Analytics. The estimated cost of development with Jabil and Mobile Now is approximately $1.2 to $1.5 million US. As such, the agreement calls for CA to provide timely reporting and status of product development including timelines, milestones and dates of completion and delivery of product (market readiness, product volume availability and delivery terms and schedules). Many strides have been made in the evolution of the relationship as CA has established its operations, initial staffing and funding. Both CI and CA are in a mode of cooperation, as called for by the Agreement and, presently, both entities are to hold routine meetings where comprehensive updating and reporting will be delivered to CI, enabling implementation of our business, operations and marketing plans. We will be reporting the outcomes of that meeting to move forward on our ability to commercialize the iTBra™ system this year. Given the above, we would like to update on the internal operations that will allow for CI to “hit the ground running” upon product delivery. Status of Product Development and Manufacturing Under CA’s...

Welcome to Lifeline Biotechnologies Inc. (LLBO) Board!!!

Clinical Trial

In Progress - To Be Completed

** Funding for Clinical Trial

** Vendor delivery of testing materials

Completed for Clinical Trial

** Protocol for testing accepted

** Internal Review Board (IRB) approved

** Contract with hospital executed

Prospective Partner

** Stanford University's Canary Research

Research in blood genomics


The Mastascope is an ultraslim, hand held endoscope designed to enter the breast nipple via one of its milk ducts, thus permitting the physician to visualize the interior aspects of the breast. Because many cancers actually begin within an individual milk duct, these intraductal tumors are visualized easily and can be biopsied. This product has been used in leading breast centers in the United Kingdom and other countries with great success. Lifeline has obtained a CE mark for marketing and distribution in Europe. 


Lifeline has developed and tested an ultraslim endoscope to directly visualize the ovarian surface in the search for cancer. This is of great advantage to physicians, because neither MRI, X-Ray nor Ultrasonography can provide accurate assessments of subtle surface changes. Initial reports of clinical usage have been encouraging.

About $LLBO - Lifeline Biotechnologies, Inc.

About Lifeline Biotechnologies:

Lifeline Biotechnologies, Inc. (OTC Market: LLBO) founded in 1994 is based in Reno, NV.  LLBO has invested over $10M in a device and process for early detection of breast tissue abnormalities some of which are cancerous or pre-cancer.  Three “Proof of Concept” clinical trials of over 500 women have been completed and three patents (one hardware, two software) have been awarded. 

Safe Harbor:

This publication includes forward-looking statements within the meaning of Section 27A of the Securities Act of 1933 and Section 27E of the Securities Act of 1934. Statements contained in this release that are not historical facts may be deemed to be forward-looking statements. Investors are cautioned that forward-looking statements are inherently uncertain. Actual performance and results may differ materially from that projected or suggested herein due to certain risks and uncertainties including, without limitation, the ability to obtain financing, successful development of the Company's product or market acceptance of the product and regulatory and shareholder approval for anticipated actions.

http://www.firstwarningsystems.com/ became Cyrcadia Health http://cyrcadiahealth.com/

$LLBO is Cyrcadia's largest shareholder at approximately 40%

Transfer Agent

OTC Corporate Transfer Service Co.
52 Maple Run Drive
Jericho, NY 11753

Share Structure
Shares Outstanding 3,026,680,967 a/o Sep 30, 2014
Float 650,000,000 a/o Jun 30, 2009
Authorized Shares 4,950,000,000 a/o Sep 30, 2014
Par Value 0.001

Company Information

About Lifeline Biotechnologies:

Lifeline Biotechnologies, Inc. (OTC Market: LLBO) founded in 1994 is based in Reno, NV.  LLBO has invested over $10M in a device and process for early detection of breast tissue abnormalities some of which are cancerous or pre-cancer.  Three “Proof of Concept” clinical trials of over 500 women have been completed and three patents (one hardware, two software) have been awarded. http://www.lbti.com

About Cyrcadia Health

Cyrcadia Health founded in 2008, is based in Reno, Nev. The Cyrcadia Health product line is a device and software service that detects breast tissue abnormalities leading to health risk assessment and management including early breast cancer identification. Three clinical trials with over 650 participants have achieved proof of concept and superior outcomes when compared to other diagnostic protocols. Cyrcadia Health technology is exclusively licensed for development, manufacturing and marketing worldwide from Lifeline Biotechnologies, Inc (OTC Market: LLBO). Cyrcadia Health is planning a final, limited clinical trial and a 510k device classification to validate the fourth generation of the FWS product. Cyrcadia Health is preparing to apply for a Euro CE Mark to market in the European Union and Asia Pacific markets. See Cyrcadia Health video, “Breast Cancer Tumor Progression” at http://www.cyrcadiahealth.com/

iTBra in the News

ABC 7 News - February 5, 2015


ABC 7 News - February 5, 2015

ABC 7 News - January 30, 2015

Good Monring America apperance coming....
Quote from the March 12, 2015 PR

They also interviewed Rob Royea (Cyrcadia's President) for a feature story on Good Morning America expected to air in the next coming months.


Could a Bra Actually Detect Breast Cancer?
By Smithsonian Magzine




Documentary Movie: Detected coming....
Funded by Cisco
Detected Trailer...

Detected trailer on Cisco's facebook page
Detected: Behind the Scenes with Ironbound Films
Meet Chief Evangelist Behind Cancer-Detecting iTBra, Rob Royea

How the Internet of Everything is Changing Healthcare

Can the IoE Save Lives? Connected Bra Could Predict Cancer
By: Cisco's Senior Vice President and Chief Marketing Officer

Detected Website http://detectedmovie.com/
Detected Facebook https://www.facebook.com/detectedmovie
Detected Twitter https://twitter.com/detectedmovie

Partnered with Flextronics

Cyrcadia Health Partners

In Israel at Flextronics



iTBra Already Saved Nedra Lindsay's Life - See Her Story

Final Clinical Trials, FDA plans and other info from - March 12, 2015 Press Release

...Cyrcadia prepares to enter the final clinical trials that will be conducted at El Camino Hospital (ECH) in Mountain View, CA and the Ohio State University (OSU) Oncology Hospital in Columbus, OH. The trials have been approved through Investigational Review Boards (IRB's) of ECH and are currently undergoing the review process at OSU. The ECH trial is slated for start before the end of April 2015. The trials are expected to be completed in four to 6 months. On completion Cyrcadia will obtain CE Marking allowing for sales and marketing outside of the USA. On completion of the trials Cyrcadia will be submitting a 510(k) to the FDA. Post clearance, marketing will begin in the USA. International sales are expected in Q4 of 2015 and US sales in Q1 or Q2 of 2016.


It is interesting to note that Dr. Farrar at OSU will be the primary investigator for the trials conducted at OSU. Dr. Farrar headed the original "proof of concept" study that was conducted at OSU.


Stanford University Canary Center for Early Cancer Detection has pledged $187,000 to help fund the equipment for the trials at El Camino Hospital.


They also interviewed Rob Royea (Cyrcadia's President) for a feature story on Good Morning America expected to air in the next coming months.




Detected Movie Youtube channel

Video News Clipping ABC7 Los Angeles Health News - Breast Cancer Detecting Bra

Detected: Behind the Scenes with Ironbound Films

Wearable & Social Breast Cancer Screening

Meet Chief Evangelist Behind Cancer-Detecting iTBra, Rob Royea

How the Internet of Everything is Changing Healthcare

GameChanger of the Year: Cyrcadia

$LLBO infograph, DD in a nutshell

Current Price
Bid Ask Day's Range
  • 1D
  • 1M
  • 2M
  • 3M
  • 6M
  • 1Y
  • 2Y
  • 3Y
  • 5Y
#30620   You may sent the report to chris.de.vuyst1@telenet.be as Be aware 09/17/20 02:47:49 AM
#30619   Very nice and informative report, the only thing yaro1 09/17/20 02:30:25 AM
#30618   Hi Lep: once you read and analyzed it, Arnie1 09/16/20 04:24:17 PM
#30617   Bibioo, Would love to read what they are sven 09/16/20 03:03:33 PM
#30616   Can share it too , if you are interested..........;-) leprisonnier 09/16/20 02:12:41 PM
#30615   i have it, question of time lol. i leprisonnier 09/16/20 01:55:07 PM
#30614   Hi , i would lime to yaronissan1@gmail.com Thanks a lot!! yaro1 09/16/20 01:45:05 PM
#30613   I have already bought the article. Its has Bibioo 09/16/20 01:11:54 PM
#30612   have bought the article but problem to download leprisonnier 09/16/20 12:01:48 PM
#30611   You are welcome leprisonnier 09/16/20 10:27:37 AM
#30610   Lep: Great find!! I think FDA approval is Arnie1 09/16/20 08:53:35 AM
#30609   Ps. I shared the article with my rrao11 09/16/20 07:32:29 AM
#30608   Not sure if u will get any more rrao11 09/16/20 07:15:34 AM
#30607   I think to buy the article to have leprisonnier 09/16/20 07:01:51 AM
#30606   Awesome find! Thanks for sharing. L&S rrao11 09/16/20 06:50:51 AM
#30605   https://www.sciencedirect.com/science/article/abs/pii/S0169260720315911 leprisonnier 09/16/20 03:52:16 AM
#30604   techead: I received an email from a very Arnie1 09/14/20 03:56:35 PM
#30603   Where did u read of this info techhead 09/14/20 12:09:39 PM
#30602   Luckyuu and to all Investors: Latest info: Arnie1 09/12/20 08:40:57 AM
#30601   Long and strong LLBO <3 Luckyyu 09/12/20 02:59:58 AM
#30600   Hi Longs, patience . Long and Strong. leprisonnier 09/12/20 02:34:18 AM
#30599   Arnie1, I believe so too! Let’s hope Luckyyu 09/11/20 11:18:00 AM
#30598   Luckyyu: Thanks, I am doing well !! I Arnie1 09/11/20 11:11:09 AM
#30597   Agreed!!! Best regards Arnie1. Luckyyu 09/11/20 10:22:53 AM
#30596   techead:Those Investors who are patient will be rewarded!! Arnie1 09/11/20 08:44:03 AM
#30595   Good PPS—$.14 Price Per Share (updated from my confirm 09/10/20 05:22:06 PM
#30594   Why would anyone want to invest in a PharrmaBro 09/10/20 03:09:27 PM
#30593   This is getting old waiting ....... techhead 09/10/20 11:31:24 AM
#30592   Unfortunately, when they stopped filing with the SEC sven 08/25/20 09:49:01 AM
#30591   Greatest melt-up in stock market history! tonyb2232 08/25/20 01:32:52 AM
#30590   I agree. You can sometimes find information on tonyb2232 08/21/20 02:12:24 PM
#30589   I wish we had some new info/updates. Very stolijohn 08/21/20 08:02:32 AM
#30588   E-7-2: I agree!! The volume is up 1.7 Arnie1 08/17/20 10:33:10 AM
#30587   Arnie, I think investors in Asia have figured E-7-2 08/17/20 10:24:22 AM
#30586   E-7-2: I tend to agree with you!! I Arnie1 08/15/20 04:06:44 PM
#30585   The intellectual property own by Cyrcadia might be E-7-2 08/15/20 01:23:02 PM
#30584   E-7-2: I agree that people are buying the Arnie1 08/15/20 09:33:13 AM
#30583   Thanks E leprisonnier 08/15/20 08:20:25 AM
#30582   Cyrcadia is getting a lot of press regarding E-7-2 08/14/20 06:18:05 PM
#30581   Thanks ?? leprisonnier 08/13/20 03:03:05 PM
#30580   You guys still here. You shoud come to intexp 08/13/20 12:17:25 PM
#30579   U r correct, many time. But look rrao11 08/07/20 11:30:49 PM
#30578   How many times have we heard that one ? techhead 08/07/20 08:28:12 PM
#30577   wont hold my breath.... but no harm in hoping! frodo66 08/07/20 03:26:26 PM
#30576   Looks like someone knows something! rrao11 08/07/20 03:23:58 PM
#30575   a little action here today.. frodo66 08/07/20 10:22:33 AM
#30574   I agree with your post 100%. Chaka 08/07/20 01:13:15 AM
#30573   Well said brogger 08/06/20 02:09:35 PM
#30572   Hello again. I see this all the time Ibcnu 08/06/20 01:03:32 AM
#30571   I think the time has come techhead 08/03/20 06:45:11 PM
Consent Preferences